Biotechnology Industry in Australia FINAL

8/12/2019 Biotechnology Industry in Australia FINAL

1/15

Vaishali Bhagat (NR12011)

Rucha Dave (NR12030)

8/12/2019 Biotechnology Industry in Australia FINAL

2/15

Present Scenario Leading companies

Regulatory regime

R&D Government support

GAP analysis

Future of industry

On the horizon

conclusion

8/12/2019 Biotechnology Industry in Australia FINAL

3/15

Excellent research facilities

World-class scientists

Strong but flexible regulatory regime

8/12/2019 Biotechnology Industry in Australia FINAL

4/15

In 2010-12, the industry generated A$7.48 billion in

revenue

(Source: IBIS World Industry Report, Biotechnology in

Australia, page 5, March 2012).

Companies specialize predominately in human

therapeutics (49 per cent),

Agri-biotech (16 per cent),

Diagnostics (13 per cent),

Others operating in the fields of chemicals, the

environment, food and beverages and

bioinformatics

(Source: Ibid page 16).

8/12/2019 Biotechnology Industry in Australia FINAL

5/15

Starpharma Holdingshas a drug delivery collaboration agreement with Eli Lillyand Company for human pharmaceuticals

Biota Holdings Limitedhas partnered with Daiichi Sankyo to develop theinfluenza drug laninamivir

Universal Biosensorshas partnered with Johnson & Johnsons LifeScan on

glucose meters and sensors

Mesoblasthas entered into a strategic alliance with Cephalon Inc. (now TEVA) tocommercialize its adult stem sell technologies

Bionomics and Merck Seronohave a research collaboration to develop

compounds for the treatment of Multiple Sclerosis

Alchemiahas a collaborative partnership with Dr Reddys Laboratories Limited formarketing generic fondaparinux in America.

Phylogicahas drug discovery collaboration agreements with Pfizer, MedImmune

(the biologics unit of AstraZeneca) and Roche.

8/12/2019 Biotechnology Industry in Australia FINAL

6/15

The industry also has a strong drug development pipeline,with around 6,100 clinical trials registered in Australiabetween July 2005 and January 2012

(Source:Australian New Zealand Clinical Trials Registry).

The clinical trials sector is worth around A$1 billion perannum to the Australian economy each year with directforeign investment of over A$450 million per annum

(Source: Australian Government Clinically Competitive: ClinicalTrials Action Group Report, page 17, March 2011).

Efficient regulatory framework, particularly in intellectualproperty protection

8/12/2019 Biotechnology Industry in Australia FINAL

7/15

Sophisticated R&D infrastructure

Home to world renowned research organisations such asthe(CSIRO)

Research facilities such as the (APAF) the worlds first

dedicated proteome centre;

World-class medical research institutes, including the Walter andEliza Hall Institute, the Garvan Institute of Medical Research,and the Florey Neuroscience Institutes.

Worlds largest life sciences supercomputing facilities is alsobased in Australia

8/12/2019 Biotechnology Industry in Australia FINAL

8/15

Providing funding to the nations premier scientific research

agency, CSIRO, and its work with industry, government and theAustralian research community.

Commercialization Australia has funding of A$278 million over fiveyears to 2014, with a further A$82 million allocated for each year

thereafter (Source: Commercialization Australia).

In the 2011/12 Federal Budget, the Government allocated anestimated A$9.4 billion)in support of Australian science, researchand innovation over the 2011/12 financial year.

(Source:Australian Government Media Release, 10 May 2011).

8/12/2019 Biotechnology Industry in Australia FINAL

9/15

R&D Tax Incentive

Indo-Australian Biotechnology Fund

Commercialization Australia

Linkage Projects

Enterprise Connect

Innovation Investment Fund

A National Enabling Technologies Strategy

8/12/2019 Biotechnology Industry in Australia FINAL

10/15

Improved crops with innovative research

Offers untapped wealth of opportunity.

Recognized strength

Exciting opportunities for investors and partners.

Development of new GM technology.

8/12/2019 Biotechnology Industry in Australia FINAL

11/15

International attention-Open for business

Strong opportunity in different sector

Australias true-blue untapped opportunities

Australian partnership and alliances

Infrastructure networks in the industry strongly encourage

technology transfer and the commercialization of

intellectual property.

8/12/2019 Biotechnology Industry in Australia FINAL

12/15

Protection of cotton crops from pests

Unique biodiversity

Gaining credibility

Improve understanding in all fields of biotechnology

Agricultural biotechnology sector

Industry leaders

Independent national system

Future competitiveness

8/12/2019 Biotechnology Industry in Australia FINAL

13/15

The biotechnology sector in Australia presents many opportunitiesfor investment, from licensing agreements with Australianresearch entities to setting up Australian operations as a gatewayto the quickly growing Asia-Pacific market and establishing R&Dcollaborations and R&D centers.

Australian biotechnology industry have a great opportunities totouch untapped market in the same sector by opening thebusiness market for all.

Agricultural biotechnology, and the investment, innovation and

skills that underpin it, are at the top of Australias globallyrecognized strength in biotechnology research.

Innovation in different fields of bio-technology is increasing whichleads to overall development of bio-technology sector of Australia.

8/12/2019 Biotechnology Industry in Australia FINAL

14/15

Strong opportunities exist in agri biotech, immunology,stem cells, reproductive medicine, neurosciences, infectiousdiseases, cancer, and also in cross-sectoral activities such

as proteomics, bioinformatics and bio prospecting.

Australian partnerships and alliances in major biotechmarkets are now commonplace.

With an independent national system, companies will gainsecurity for their investment, will see a clear path tomarket, and will have a sound R&D base on which toconstruct a solid business model.

A key issue is the future competitiveness of Australiasfarmers in markets that provide the opportunity to capturegreater downstream value in novel products.

8/12/2019 Biotechnology Industry in Australia FINAL

15/15